Tatjana Kolupajeva

Circulation of pertussis and poor protection against diphtheria among middle-aged adults in 18 European countries

M. Avdičová, Z. Molnár, S. Brisse, 2020, Nature Communications.

Role of Interferon-Gamma (Ifn-γ) in Immune Response Regulation in Hiv-1 and Hiv-1 + Mycobacterium Tuberculosis (Tb) Infected Patients / Interferona-gamma (Ifn-γ) Loma Imūnās Atbildes Regulēšanā Pacientiem Ar HIV-1 un HIV-1 + mycobacterium Tuberculosis

E. Hagina, B. Rozentāle, A. Lejnieks, 2016 .

Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe

Jan Albert, Kirsi Liitsola, Mario Poljak, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

HIV-1 subtype distribution and its demographic determinants in newly diagnosed patients in Europe suggest highly compartmentalized epidemics

Klaus Korn, Kristof Theys, Anne-Mieke Vandamme, 2013, Retrovirology.

Patterns of Transmitted HIV Drug Resistance in Europe Vary by Risk Group

M. Poljak, R. Paredes, K. Korn, 2014, PloS one.

Increase in transmitted resistance to non-nucleoside reverse transcriptase inhibitors among newly diagnosed HIV-1 infections in Europe

M. Poljak, A. Wensing, R. Paredes, 2014, BMC Infectious Diseases.

Low prevalence of transmitted drug resistance among newly diagnosed HIV‐1 patients in Latvia

J. Albert, B. Rozentāle, D. Balode, 2010, Journal of medical virology.

Limited cross-border infections in patients newly diagnosed with HIV in Europe

M. Poljak, A. Wensing, R. Paredes, 2013, Retrovirology.

Rapid epidemic spread of HIV type 1 subtype A1 among intravenous drug users in Latvia and slower spread of subtype B among other risk groups.

T. Leitner, B. Rozentāle, L. Vīksna, 2004, AIDS research and human retroviruses.

HIV drug resistance tendencies in Latvia.

B. Rozentāle, L. Vīksna, L. Guseva, 2008, Central European journal of public health.

Phylogenetic analysis of the Latvian HIV-1 epidemic.

T. Leitner, J. Albert, Mattias Mild, 2012, AIDS research and human retroviruses.